Featured review: What are the benefits and risks of light therapy for treating atopic eczema?
Cochrane Skin is pleased to announce the publication of a new review,Phototherapy for atopic eczema. This review was led by dermatologists from Amsterdam University Medical Centers, and supported by a key stakeholder: the American Academy of Dermatology (AAD). The AAD provided funding for this systematic review (32 studies, 1219 people with clinically diagnosed atopic eczema), which enabled publication of the protocol and full review within 13 months of title registration.Key messagesNarrowband (NB) ultraviolet B (UVB), compared to placebo (a sham treatment), may improve eczema severity (including itch) and may not affect ...
Source: Cochrane News and Events - November 4, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news
My life's in danger from an allergy - but no one can tell me what it is!
After dutifully using the supplied hand sanitiser in a shop last summer, Emma Bennett's hands started swelling, becoming noticeably bigger as well as incredibly itchy within minutes. (Source: the Mail online | Health)
Source: the Mail online | Health - November 2, 2021 Category: Consumer Health News Source Type: news
New Comprehensive Phase 3 Data Show First-in-Class TREMFYA ® (guselkumab) Provided Durable Improvements in Measures of Psoriatic Arthritis (PsA) Disease Activity Through Two Years
SPRING HOUSE, PENNSYLVANIA, November 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced comprehensive efficacy and safety data from the DISCOVER–2 trial of TREMFYA® (guselkumab) were published in Arthritis & Rheumatology, representing the final results of the first two-year clinical trial investigating a selective interleukin (IL)-23 inhibitor therapy in active psoriatic arthritis (PsA).1 Results show a majority of TREMFYA-treated biologic-naïve adult patients with active PsA achieved improvements in joint signs and symptoms (American College of Rheumatology [ACR] 20/50/70)a a...
Source: Johnson and Johnson - November 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
New Study Says Aggressive Immune Response Causes “Covid Toes”
The red, itchy and burning toes are a result of a strong immune response to the coronavirus that causes Covid-19, says a new study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 13, 2021 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma & Source Type: news
New Study Says Aggressive Immune Response Causes ‘Covid Toes’
The red, itchy and burning toes are a result of a strong immune response to the coronavirus that causes Covid-19, says a new study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 13, 2021 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma & Source Type: news
In AD Trial, Abrocitinib Relieves Itch Faster Than Dupilumab In AD Trial, Abrocitinib Relieves Itch Faster Than Dupilumab
In a direct comparison of the oral JAK inhibitor abrocitinib to the IL-4/IL-13 inhibitor dupilumab for AD, abrocitinib offered several advantages, including faster relief of itch.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 5, 2021 Category: Dermatology Tags: Dermatology News Source Type: news
What Causes a Child to Itch All Over?
Title: What Causes a Child to Itch All Over?Category: Diseases and ConditionsCreated: 10/5/2021 12:00:00 AMLast Editorial Review: 10/5/2021 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - October 5, 2021 Category: Pediatrics Source Type: news
How a miserable itch sent a young company to its first drug approval for a deadly disease
The Peninsula company's first FDA-approved drug will cost close to $400,000 a year. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 30, 2021 Category: American Health Authors: Ron Leuty Source Type: news
How a miserable itch sent a young company to its first drug approval for a deadly disease
The Peninsula company's first FDA-approved drug will cost close to $400,000 a year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 29, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
How a miserable itch sent a young company to its first drug approval for a deadly disease
The Peninsula company's first FDA-approved drug will cost close to $400,000 a year. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 29, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news
How to Help Relieve Dry Eyes
That gritty, itchy feeling in your eyes can arise from many causes, including too much screen time, and eye drops may only make it worse. (Source: NYT Health)
Source: NYT Health - September 20, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Eyes and Eyesight Content Type: Service Anxiety and Stress Estrogen Eyeglasses Protective Clothing and Gear Post-Traumatic Stress Disorder Cataracts Chronic Obstructive Pulmonary Disease Hormones Source Type: news
Why poison ivy can make your skin so itchy
Be on the lookout for the plant’s three leaves on a reddish stem. When you’re in the great outdoors, be careful what you touch. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 12, 2021 Category: Consumer Health News Authors: Arthur Samia Source Type: news
Eczema treatment: The 5 ways to heal eczema - from skin diaries to probiotics
ECZEMA is itchy and irritating, but you don't have to put up with it. Here are five ways to heal eczema. (Source: Daily Express - Health)
Source: Daily Express - Health - September 11, 2021 Category: Consumer Health News Source Type: news
Consider Itch and Joint Pain in Pediatric Psoriasis Patients Consider Itch and Joint Pain in Pediatric Psoriasis Patients
About 1% of pediatric psoriasis patients have psoriatic arthritis, which is much less common than in adults is"but important to find and manage."Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 3, 2021 Category: Dermatology Tags: Dermatology News Source Type: news
Mayo Clinic Minute: Patch testing for allergic contact dermatitis
If you've ever experienced a red, itchy rash appear on your skin after using a certain lotion or even from wearing jewelry, you may be experiencing contact dermatitis. It's caused by a substance you're exposed to that irritates your skin. However, it also can be triggered by an allergic reaction.In this Mayo Clinic Minute, Dr. Matthew Hall, a Mayo Clinic dermatologist, explains how patch testing is crucial to assess for allergic contact dermatitis. Watch: The… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 3, 2021 Category: Databases & Libraries Source Type: news
